Abstract
Nucleic acid molecules are designed to interact predominantly with proteins or complementary nucleic acids. Interaction of nucleic acids with carbohydrates, abundant constituents of glycoproteins and glycolipids, are not common in cells. Biomedical applications of nucleic acids targeted against oligosaccharides, which are involved in the function of receptors, immune answer, host interaction with invading infectious agents, and cancer metastasis, are feasible. In vitro selection of nucleic acids interacting with oligo- and polysaccharides is a promising strategy to identify potential inhibitors of biochemical recognition processes in which carbohydrates are involved. Several RNA and DNA aptamers directed against carbohydrates have already been isolated and characterized. The results are summarized in this article, and an attempt is made to draw initial conclusions concerning the perspectives of the outlined approach.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cowan JA, Ohyama T, Wang D, Natarajan K (2000) Recognition of a cognate RNA aptamer by neomycin B: quantitative evaluation of hydrogen bonding and electrostatic interactions. Nucleic Acids Res 28:2935–2942
Dougan H, Weitz JI, Stafford AR, Gillespie KD, Klement P, Hobbs JB, Lyster DM (2003) Evaluation of DNA aptamers directed to thrombin as potential thrombus imaging agents. Nucl Med Biol 30:61–72
Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822
Fukusaki E, Kato T, Maeda H, Kawazoe N, Ito Y, Okazawa A, Kajiyama S, Kobayashi A (2000) DNA aptamers that bind to chitin. Bioorg Med Chem Lett 10:423–425
Hanski C, Hanski ML, Zimmer T, Ogorek D, Devine P, Riecken EO (1995) Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer. Cancer Res 55:928–933
Hermann T (2005) Drugs targeting the ribosome. Curr Opin Struct Biol 15:355–366
Hermann T, Patel DJ (2000) Adaptive recognition by nucleic acid aptamers. Science 287:820–825
Hermann T, Westhof E (1998) Saccharide-RNA recognition. Biopolymers 48:155–165
Hermann T, Westhof E (1999) Docking of cationic antibiotics to negatively charged pockets in RNA folds. J Med Chem 42:1250–1261
Hermann T, Westhof E (2000) Rational drug design and high-throughput techniques for RNA targets. Comb Chem High Throughput Screen 3:219–234
Jeong S, Eom T, Kim S, Lee S, Yu J (2001) In vitro selection of the RNA aptamer against the Sialyl Lewis X and its inhibition of the cell adhesion. Biochem Biophys Res Commun 281:237–243
Jiang L, Patel DJ (1998) Solution structure of the tobramycin-RNA aptamer complex. Nat Struct Biol 5:769–774
Kawakami J, Kawase Y, Sugimoto N (1998) In vitro selection of aptamers that recognize a monosaccharide. Anal Chim Acta 365:95–100
Klussmann S, Nolte A, Bald R, Erdmann VA, Furste JP (1996)Mirror-image RNA that binds D-adenosine. Nat Biotechnol 14:1112–1115
Kwon M, Chun SM, Jeong S, Yu J (2001) In vitro selection of RNA against kanamycin B. Mol Cells 11:303–311
Lasky LA (1995) Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu Rev Biochem 64:113–139
Masud MM, Kuwahara M, Ozaki H, Sawai H (2004) Sialyllactose-binding modified DNA aptamer bearing additional functionality by SELEX. Bioorg Med Chem 12:1111–1120
Nimjee SM, Rusconi CP, Sullenger BA (2005) Aptamers: an emerging class of therapeutics. Annu Rev Med 56:555–583
Nolte A, Klussmann S, Bald R, Erdmann VA, Furste JP (1996) Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nat Biotechnol 14:1116–1119
Osborne SE, Matsumura I, Ellington AD (1997) Aptamers as therapeutic and diagnostic reagents: problems and prospects. Curr Opin Chem Biol 1:5–9
Patel DJ, Suri AK (2000) Structure, recognition and discrimination in RNA aptamer complexes with cofactors, amino acids, drugs and aminoglycoside antibiotics. J Biotechnol 74:39–60
Patel DJ, Suri AK, Jiang F, Jiang L, Fan P, Kumar RA, Nonin S (1997) Structure, recognition and adaptive binding in RNA aptamer complexes. J Mol Biol 272:645–664
Rusconi CP, Roberts JD, Pitoc GA, Nimjee SM, White RR, Quick G Jr, Scardino E, Fay WP, Sullenger BA (2004) Antidote-mediated control of an anticoagulant aptamer in vivo. Nat Biotechnol 22:1423–1428
Srisawat C, Goldstein IJ, Engelke DR (2001) Sephadex-binding RNA ligands: rapid affinity purification of RNA from complex RNA mixtures. Nucleic Acids Res 29:E4
Tereshko V, Skripkin E, Patel DJ (2003) Encapsulating streptomycin within a small 40-mer RNA. Chem Biol 10:175–187
Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510
Wang Y, Killian J, Hamasaki K, Rando RR (1996) RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities. Biochemistry 35:12338–12346
Weintraub A (2003) Immunology of bacterial polysaccharide antigens. Carbohydr Res 338:2539–2547
Weis WI, Drickamer K (1996) Structural basis of lectin-carbohydrate recognition. Annu Rev Biochem 65:441–473
White RR, Shan S, Rusconi CP, Shetty G, Dewhirst MW, Kontos CD, Sullenger BA (2003) Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci USA 100:5028–5033
Yang Q, Goldstein IJ, Mei HY, Engelke DR (1998) DNA ligands that bind tightly and selectively to cellobiose. Proc Natl Acad Sci USA 95:5462–5467
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sprinzl, M., Milovnikova, M., Voertler, C. (2006). RNA Aptamers Directed Against Oligosaccharides. In: Erdmann, V., Barciszewski, J., Brosius, J. (eds) RNA Towards Medicine. Handbook of Experimental Pharmacology, vol 173. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27262-3_16
Download citation
DOI: https://doi.org/10.1007/3-540-27262-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-27261-8
Online ISBN: 978-3-540-27262-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)